CVS Health is expected to move away from the complex formulas used to set the prices of the prescription drugs it sells, shifting to a simpler model that could change how much Americans pay.
A dual-chamber wireless pacemaker provides reliable performance over three months, bolstering evidence for this new option, according to results from a multi-center international clinical trial co-led by a Weill Cornell Medicine investigator.
ACT for Youth, which promotes adolescent health and well-being in New York state, has been awarded $5 million to help local health departments improve care for youth with special needs.
A new project seeks to develop methodologies to assess food environments in two Kenyan cities, understand the role of informal vendors and offer guidance on how to measure the rapidly changing food environments.
The annual competition, slated for Nov. 10-13, allows students to work on open-ended real world problems, showcasing the multifaceted nature of applied mathematics.
Women are at higher risk of death when undergoing heart bypass surgery than men, and researchers have determined that this disparity is mediated, to a large extent, by the loss of red blood cells during surgery.
Osei Boateng ’18, MHA ’20, founder of OKB Hope Foundation, a nonprofit dedicated to transforming health care delivery in Africa, is the latest guest on the Startup Cornell podcast.
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs.
A study identifies microbes that potentially play important roles in breaking down harmful PFAS chemicals and points to functional genes that may be involved.